Progelatinase B/matrix metalloproteinase-9 proenzyme as a marker of pleural inflammation

Experimental Lung Research

Volumn 30, Issue 4, 2004, Pages 297-309

  Kotyza, Jaromír ^a   Pešek, Miloš ^a   Pužman, Petr ^a   Havel, David ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Interleukin 6; Matrix metalloproteinase 9; Pleural injury; Talc pleurodesis

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; GELATINASE B; INTERLEUKIN 6; MORPHINE; PROGELATINASE B; TALC; TRAMADOL; TRIMECAINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE MARKER; ELECTROPHORESIS; FEMALE; FEVER; HUMAN; HYPOTENSION; LEUKOCYTE COUNT; MALE; NEUTROPHIL; PLEURA EFFUSION; PLEURA FLUID; PLEURODESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIDE EFFECT; SUBCUTANEOUS EMPHYSEMA; THORACOSCOPY; THORAX PAIN;

AGED; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; ENZYME PRECURSORS; FEMALE; GELATINASES; HUMANS; INFLAMMATION; INTERLEUKIN-6; L-LACTATE DEHYDROGENASE; LEUKOCYTE COUNT; MALE; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MIDDLE AGED; PLEURA; PLEURAL EFFUSION; PLEURODESIS; TALC; THORACOSCOPY; TREATMENT OUTCOME;

EID: 2642550163     PISSN: 01902148     EISSN: None     Source Type: Journal    
DOI: 10.1080/01902140490276393     Document Type: Article

References (39)

1. Owen CA, Campbell EJ: The cell biology of leukocyte-mediated proteolysis. J. Leukoc Biol. 1999;65:137-150.
2. Nelson AR, Fingleton B, Rothenberg ML, et al: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol. 2000;18:1135-1149.
3. Dano K, Romer J, Nielsen BS, et al: Cancer invasion and tissue remodeling - cooperation of protease systems and cell types. APMIS. 1999;107:120-127.
4. Kupferman ME, Fini ME, Muller WJ, et al: Matrix metalloproteinase 9 promoter activity is induced coincident with invasion during tumor progression. Am J Pathol. 2000;157:1777-1783.
5. Itoh T, Tanioka M, Matsuda H, et al: Experiment 21 metastasis is suppressed in MMP-9-deficient mice. Clin Exp Metastasis 1999;17:177-181.
6. Collier IE, Goldberg GI. Gelatinase B. In: Barrett AJ, Rawlings ND, Woessner JF, eds. Handbook of Proteolytic Enzymes. San Diego, London, Boston, New York: Academic Press; 1998:1205-1210.
7. Trocme C, Gaudin P, Berthier S, et al: Human B lymphocytes synthetize the 92-kDa gelatinase, MMP-9. J Biol Chem. 1998;273:20677-20684.
8. Okada S, Kita H, George TJ, et al: Migration of eosinophiles through basement membrane components in vitro: role of matrix metalloproteinase-9. Am J Respir Cell Mol Biol. 1997;17:519-528.
9. Opdenakker G, Van den Steen PE, Dubois P, et al: Gelatinase B functions as regulator and efector in leukocyte biology. J Leukoc Biol. 2001;69:851-859.
10. Opdenakker G, Van den Steen PE, Van Damme J: Gelatinase B: a tuner and amplifier of immune functions. Trends Immunol. 2001;22:571-579.
11. Marshall BC, Santana A, Xu QP, et al: Metalloproteinases and tissue inhibitors of metalloproteinases in mesothelial cells. Cellular differentiation influences expression. J Clin Invest. 1993;91:1792-1799.
12. Hurewitz AN, Zucker S, Manusco P, et al: Human pleural effusions are rich in matrix metalloproteinases. Chest. 1992;102:1808-1814.
13. Eickelberg O, Sommerfeld CO, Wyser C, et al: MMP and TIMP expression pattern in pleural effusions of different origins. Am J Respir Crit Care Med. 1997;156:1987-1992.
14. Eickelberg O, Reichenberger F, Larx R, Tamm M, Habicht J, Wyser C, Roth M, Soler M, Perruchoud AP: Quantitative analyses of MMP- and TIMP-isoforms in pleural effusions of different origin. Meeting of the American Thoracic Society. 1998; Abstract D23.
15. Kotyza J, Havel D, Pešek M, Lošan F: Expression of metalloproteinases MMP-2 and MMP-9 in malignant pleural effusions. Studia Pneumol Phthiseol. 2002;62:64-70.
16. Opal SM, DePalo VA: Anti-inflammatory cytokines. Chest. 2000;117:1162-1172.
17. Lin CC, Liu CC, Lin CY, et al: Changes in cell population and tumor necrosis factor, interleukin-6, and interleukin-8 in malignant pleural effusions after treatment with intrapleural tetracycline. Am Rev Respir Dis. 1993;147:1503-1506.
18. Yokoyama A, Maruyama M, Ito M, et al: Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoeietic activity. Chest. 1998;102:14-17.
19. Hoheisel G, Izbicki G, Roth M, et al: Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy. Respir Med. 1998;92:14-17.
20. Hoheisel G, Izbicki G, Roth M, et al: Proinflammatory cytokine levels in patients with lung cancer and carcinomatous pleurisy. Respiration. 1998;65:183-186.
21. Alexandrakis MG, Coulocheri SA, Bouros D, et al: Evaluation of ferritin, interleukin-6, interleukin-8 and tumor necrosis factor alpha in the differentiation of exudates and transudates in pleural effusions. Anticancer Res. 1999;19:3607-3612.
22. Xirouchaki N, Tzanakis N, Bouros D, et al: Diagnostic value of interleukin-1α, interleukin-6, and tumor necrosis factor in pleural effusion. Chest. 2002;121:815-820.
23. Okamura JM, Miyagi JM, Terada K, et al: Potential clinical application of C-reactive protein. J Clin Labor Anal. 1990;4:231-235.
24. Garcia-Pachon E, Llorca I: Diagnostic value of C-reactive protein in exudative pleural effusions. Eur J Intern Med. 2002;13:246-249.
25. Alexandrakis MG, Coulocheri SA, Bouros D, et al: Significance of alpha-2-macroglobulin, alpha-1-acid glycoprotein, and C-reactive protein in pleural effusion differentiation. Respiration. 2000;67:30-35.
26. Kossakowska AE, Edwards DR, Prusinkiewicz C, et al: Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin lymphomas. Blood. 1999;94:2080-2089.
27. Opdenakker G, Masure S, Grillet B, Van Damme J: Cytokine-mediated regulation of human leukocyte gelatinases and role in arthritis. Lymphokine Cytokine Res. 1991;10:317-324.
28. Ross RT, Burnett CM: Talc pleurodesis: a new technique. Am Surgeon. 2001;67:467-468.
29. Sahn SA: Management of malignant pleural effusions. Monaldi Arch Chest Dis. 2001;56:394-399.
30. Kleiner DE, Stetler-Stevenson WG: Quantitative zymography: detection of picogram quantities of gelatinases. Anal Biochem. 1994;218:325-329.
31. Li Y, Borregaard N, Kjeldsen L, et al: The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase G/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). J Biol Chem. 2001;276:37258-37265.
32. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N: Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268:10425-10432.
33. Barren AJ: Alpha-2-macroglobulin. Methods Enzymol. 1981;80:737-754.
34. Han YP, Nien YD, Garner WL: Tumor necrosis factor-alpha-induced proteolytic activation of promatrix metalloproteinase-9 by human skin is controlled by down-regulation of tissue inhibitor of metalloproteinase-1 and mediated by tissue associated chymotrypsin-like proteinase. J Biol Chem. 2002;277:27319-27327.
35. Hoheisel G, Sack U, Hui DSC, et al: Occurence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis. 2001;81:203-209.
36. Larocco M: Inflammation and immunity. In: Porth CM, eds. Pathophysiology: Concepts of Altered Health States. Philadelphia: Lippincott; 1994;243-251.
37. Van den Steen PE, Proost P, Grillt B, et al: Cleavage of denatured natural collagen type II by neutrophil gelatinase B reveals enzyme specificity, post-translational modifications in the substrate, and the formation of remnant epitopes in rheumatoid arthritis. FASEB J. 2002;19:379-389.
38. Harriah H, Donia SE, Hsu CD: Amniotic fluid matix metalloproteinase-9 and interleukin-6 in predicting intra-amniotic infection. Obstet Gynecol. 2002;99:80-84.
39. Chung CL, Chen YC, Chan SC: Effect of repeated thoracenteses on fluid characteristics, cytokines, and fibrinolytic activity in malignant pleural effusion. Chest. 2003;123:1188-1195.